Association Between Drug Use and Subsequent Diagnosis of Lupus Erythematosus | Zendy

Jeanette Halskou Haugaard | Zendy; Klaus F. Kofoed | Zendy; Gunnar Gislason | Zendy; Lene Dreyer | Zendy; Alexander Egeberg | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Association Between Drug Use and Subsequent Diagnosis of Lupus Erythematosus

Author(s) -

Jeanette Halskou Haugaard,

Klaus F. Kofoed,

Gunnar Gislason,

Lene Dreyer,

Alexander Egeberg

Publication year - 2020

Publication title -

jama dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.128

H-Index - 166

eISSN - 2168-6084

pISSN - 2168-6068

DOI - 10.1001/jamadermatol.2020.2786

Subject(s) - medicine , interquartile range , odds ratio , lupus erythematosus , cutaneous lupus erythematosus , systemic lupus erythematosus , drug , population , danish , pharmacy , dermatology , immunology , disease , pharmacology , environmental health , family medicine , antibody , linguistics , philosophy

It has been estimated that up to 30% of all subacute cutaneous lupus erythematosus (CLE) cases and up to 15% of systemic lupus erythematosus (SLE) cases are drug induced. Based on numerous case reports and several epidemiologic studies, more than 100 drugs from more than 10 drug classes are suspected to cause drug-induced lupus erythematosus.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research